Skip to main content

Inbiomotion, a great example of tech transfer by Roger Gomis

Media mentions
14 Feb 17




Communication Officer
Tel.+34 93 40 37255

The Science Blog “Eduscopi” publishes an interview with ICREA researcher Roger Gomis, leader of the Growth Control and Cancer Metastasis Lab at IRB Barcelona and founder of Inbiomotion, a spin-off of IRB Barcelona and ICREA, launched in 2011.

Roger Gomis set up Inbiomotion with the aim to develop biomarkers to predict bone metastases from biopsies of primary tumors. During the interview, he explains what creating a spin-off is all about, laying special emphasis on social return on investment.

Link to Eduscopi 



About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).